首页> 外文期刊>Annals of surgical oncology >Angiopoietin-Like Protein 2 Acts as a Novel Biomarker for Diagnosis and Prognosis in Patients with Esophageal Cancer
【24h】

Angiopoietin-Like Protein 2 Acts as a Novel Biomarker for Diagnosis and Prognosis in Patients with Esophageal Cancer

机译:血管生成素样蛋白2充当食管癌患者诊断和预后的新型生物标志物

获取原文
获取原文并翻译 | 示例
       

摘要

Angiopoietin-like protein 2 (ANGPTL2) mediates chronic inflammation. Tumor cell-derived ANGPTL2 promotes tumor invasion and angiogenesis. Overexpression of ANGPTL2 in tumor cells is associated with tumor progression and has been recognized in lung, breast, colon, and gastric cancer. However, to our knowledge the functional and clinical significance of ANGPTL2 expression has not been investigated in patients with esophageal cancer (EC).
机译:血管生成素样蛋白2(ANGPTL2)介导慢性炎症。肿瘤细胞来源的ANGPTL2促进肿瘤侵袭和血管生成。 ANGPTL2在肿瘤细胞中的过表达与肿瘤进展有关,并且已在肺癌,乳腺癌,结肠癌和胃癌中得到公认。然而,据我们所知,尚未在食管癌(EC)患者中研究ANGPTL2表达的功能和临床意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号